This is a snippet of the transcript, sign up to read more.
Years ago, before 1987, when the Safe Harbor Act went into effect. This law, in my opinion, contributes to the industry's problem by allowing group purchasing organizations (GPOs) to collect fees from suppliers in the healthcare industry. In other industries, like farming, you might have a co-op or GPO where small or large farms pool resources to hire people who negotiate for fuel, fertilizer, and other necessities. These efforts are funded by the members. However, in healthcare, the purchasing personnel are funded by the suppliers, which I see as problematic.
This is a snippet of the transcript, sign up to read more.
At the end of the day, a good GPO will return around a cent on the $0.03 collected to the members. For example, the $0.03 that went to Premier, a cent should go back to the member. If you're a hospital receiving $0.0080 back on the dollar, you might question the need to hire additional staff for the same purpose.
This is a snippet of the transcript, sign up to read more.
Well, let's say they got $0.03. Premier would give back $0.015 to $0.0175 to the hospital system, which is significant. Currently, Vizient is better than Premier. Premier might give back $0.015 to $0.0175, HealthTrust might give back $0.025, and Vizient might give back $0.02. GPOs don't all return the same amount, and larger hospital systems receive a larger share back compared to smaller hospitals. This financial complexity illustrates how GPOs earn money and reimburse their members.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research